Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kedrostis foetidissima extract is a botanical extract derived from the perennial climbing herb *Kedrostis foetidissima* (family Cucurbitaceae), which is native to parts of Africa, India, and Sri Lanka. Traditionally used in folk medicine (such as Siddha medicine) to treat various ailments including measles, asthma, cough, and skin infections, the extract has been investigated for its potential antineoplastic, anti-proliferative, and apoptotic properties. In vitro studies demonstrate that the methanolic extract of *Kedrostis foetidissima* inhibits the growth of breast cancer cell lines (such as MCF-7 and YMB-1) by inducing apoptosis. This apoptotic effect is associated with the downregulation of Retinoblastoma-binding protein 6 (RBBP6) and the upregulation of tumor suppressor p53 and pro-apoptotic Bax genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kedrostis foetidissima extract.